Worldwide, the estimated prevalence of all forms of retinitis pigmentosa (RP) is 1 in 4000.[6]Cross N, van Steen C, Zegaoui Y, et al. Retinitis pigmentosa: burden of disease and current unmet needs. Clin Ophthalmol. 2022;16:1993-2010.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232096
http://www.ncbi.nlm.nih.gov/pubmed/35757022?tool=bestpractice.com
[7]Verbakel SK, van Huet RAC, Boon CJF, et al. Non-syndromic retinitis pigmentosa. Prog Retin Eye Res. 2018 Sep;66:157-86.
https://www.sciencedirect.com/science/article/pii/S1350946217300721?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/29597005?tool=bestpractice.com
Population-based studies report a relatively higher prevalence of 1 in 750 in India (1 in 372 in the rural setting and 1 in 930 in urban areas).[8]Nangia V, Jonas JB, Khare A, et al. Prevalence of retinitis pigmentosa in India: the Central India Eye and Medical Study. Acta Ophthalmol. 2012 Dec;90(8):e649-50.
https://onlinelibrary.wiley.com/doi/10.1111/j.1755-3768.2012.02396.x
http://www.ncbi.nlm.nih.gov/pubmed/22594809?tool=bestpractice.com
[9]Sen P, Bhargava A, George R, et al. Prevalence of retinitis pigmentosa in South Indian population aged above 40 years. Ophthalmic Epidemiol. 2008 Jul-Aug;15(4):279-81.
http://www.ncbi.nlm.nih.gov/pubmed/18780262?tool=bestpractice.com
A presumed period prevalence of 1 in 6500 has been reported in South Korea; incidence of RP was found to be 1.64 cases per 100,000 person-years.[10]Rim TH, Park HW, Kim DW, et al. Four-year nationwide incidence of retinitis pigmentosa in South Korea: a population-based retrospective study from 2011 to 2014. BMJ Open. 2017 May;7(5):e015531.
https://bmjopen.bmj.com/content/7/5/e015531.long
http://www.ncbi.nlm.nih.gov/pubmed/28490561?tool=bestpractice.com
The rates of autosomal dominant (ADRP), autosomal recessive (ARRP), and X-linked (XLRP) RP vary considerably from region to region. A study of medical and social service sources in Maine reported rates of 19% ADRP, 65% ARRP, and 8% XLRP.[11]Bunker CH, Berson EL, Bromley WC, et al. Prevalence of retinitis pigmentosa in Maine. Am J Ophthalmol. 1984 Mar;97(3):357-65.
http://www.ncbi.nlm.nih.gov/pubmed/6702974?tool=bestpractice.com
Mass screening in China revealed rates of 5.2% ADRP, 3.0% XLRP, and 91.8% ARRP.[12]Hu DN. Prevalence and mode of inheritance of major genetic eye diseases in China. J Med Genet. 1987 Oct;24(10):584-8.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1050283/pdf/jmedgene00084-0008.pdf
http://www.ncbi.nlm.nih.gov/pubmed/3500313?tool=bestpractice.com
In a series from the UK, rates were 39% ADRP, 25% XLRP, and 36% ARRP.[13]Jay M. On the heredity of retinitis pigmentosa. Br J Ophthalmol. 1982 Jul;66(7):405-16.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1039814/pdf/brjopthal00175-0011.pdf
http://www.ncbi.nlm.nih.gov/pubmed/7093178?tool=bestpractice.com
The age of onset is variable and depends on the mutation involved.[6]Cross N, van Steen C, Zegaoui Y, et al. Retinitis pigmentosa: burden of disease and current unmet needs. Clin Ophthalmol. 2022;16:1993-2010.
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9232096
http://www.ncbi.nlm.nih.gov/pubmed/35757022?tool=bestpractice.com
X-linked RP primarily affects males and is associated with early onset and severe disease.[14]Di Iorio V, Karali M, Melillo P, et al. Spectrum of disease severity in patients with X-linked retinitis pigmentosa due to RPGR mutations. Invest Ophthalmol Vis Sci. 2020 Dec;61(14):36.
https://iovs.arvojournals.org/article.aspx?articleid=2772123
http://www.ncbi.nlm.nih.gov/pubmed/33372982?tool=bestpractice.com
Female carriers may exhibit a wide range of atypical and/or asymmetric disease due to random x-inactivation.[15]Fahim AT, Sullivan LS, Bowne SJ, et al. X-chromosome inactivation is a biomarker of clinical severity in female carriers of RPGR-associated X-linked retinitispigmentosa. Ophthalmol Retina. 2020 May;4(5):510-20.
https://www.sciencedirect.com/science/article/abs/pii/S2468653019306347?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/31953110?tool=bestpractice.com
While some female carriers may have subclinical disease and be asymptomatic, others may exhibit severe disease with classic features of RP.[15]Fahim AT, Sullivan LS, Bowne SJ, et al. X-chromosome inactivation is a biomarker of clinical severity in female carriers of RPGR-associated X-linked retinitispigmentosa. Ophthalmol Retina. 2020 May;4(5):510-20.
https://www.sciencedirect.com/science/article/abs/pii/S2468653019306347?via%3Dihub
http://www.ncbi.nlm.nih.gov/pubmed/31953110?tool=bestpractice.com
[16]Churchill JD, Bowne SJ, Sullivan LS, et al. Mutations in the X-linked retinitis pigmentosa genes RPGR and RP2 found in 8.5% of families with a provisional diagnosis of autosomal dominant retinitis pigmentosa. Invest Ophthalmol Vis Sci. 2013 Feb;54(2):1411-6.
https://iovs.arvojournals.org/article.aspx?articleid=2128265
http://www.ncbi.nlm.nih.gov/pubmed/23372056?tool=bestpractice.com